Commercial Segment Occupying Maximum Share in the Market
Increasing healthcare expenditure across Russia, support from government and rising investment from private players are key factors fuelling the growth in this industry. Based on such key factors the pharmaceutical market is expected to foresee a double digit growth by the end of 2017. Similar to earlier years, commercial drug segment has occupied maximum share in 2012. Moreover, state segment is continuously losing its share to commercial drug segment. Even the prescription drugs in this segment have experienced faster growth...
View full press release